Document Information

Title: Samsung Bioepis to Commercialize BYOOVIZ® (ranibizumab) in Europe from January 2026

Source: https://storage.googleapis.com/polarys-documents/uploads/29c349cc-39b1-45c7-ab67-70d26657966c.txt

Content Type: press_release

Word Count: 971

Applied Auto Tags
Auto Tag Description Extracted Value Confidence Applied Actions
CEO No description Kyung-Ah Kim N/A N/A
Executives No description Linda Choi MacDonald, Anna Nayun Kim, Yoon Kim N/A N/A
Communication Type No description Press Release N/A N/A
Company No description Biogen N/A N/A
CEO No description Kyung-Ah Kim N/A N/A
About Auto Tags
Automatic Extraction

Auto tags use AI to automatically extract specific information from this document based on predefined rules.

Re-apply Tags

You can re-apply auto tags to get updated extractions if the auto tag rules have been modified.

Remove Tags

Remove individual auto tags or use "Remove All Tags" to bulk remove all applied tags at once.